Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **facial nerve** is the seventh cranial nerve (CN VII), emerging from the pons in the brainstem. It is a mixed nerve containing motor, sensory, and parasympathetic fibers. Its primary function is to control muscles responsible for facial expressions. Additionally, it conveys taste sensations from the anterior two-thirds of the tongue via its chorda tympani branch and provides parasympathetic innervation to lacrimal and salivary glands. The facial nerve also supplies somatosensory fibers to parts of the external ear. It has several segments along its course through the skull before branching into five main divisions within the face[1][2][3][4][5]. Note on correctness: The **facial nerve** itself is an anatomical structure—a mixed peripheral/cranial nerve—not a typical "therapeutic target" like receptors or enzymes at a molecular level. Therefore, it does not fit standard drug-target classification schemes used in pharmacology or drug discovery contexts[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Facial nerve (CN VII).